Skip to main content
Fig. 6 | Cancer Cell International

Fig. 6

From: The dual PI3K/mTOR inhibitor NVP-BEZ235 inhibits proliferation and induces apoptosis of burkitt lymphoma cells

Fig. 6

Dose dependent inhibition effect of NVP-BEZ235 on the phosphorylation levels of AKT (Thr308), AKT (Ser473), and PRS6 in Burkitt lymphoma cells. a results of western blot; b phosphorylation levels of AKT (Thr308), AKT (Ser473), and PRS6 in cells treated with NVP-BEZ235 at concentrations of 0, 10, 100, and 200 nmol/L for 12 h. * P < 0.05, compared with control

Back to article page